(Q21143799)

17 August 2022

14

Marie-José Stasia

Marie-José

Stasia

1 reference

17 August 2022

Ewa Bernatowska

5

Ewa

Bernatowska

1 reference

17 August 2022

19

Taco W Kuijpers

Taco W

Kuijpers

1 reference

17 August 2022

12

Joachim Roesler

Joachim

Roesler

1 reference

17 August 2022

J Merlijn van den Berg

1

J Merlijn

van den Berg

J Merlijn van den Berg

1 reference

17 August 2022

13

Reinhard Seger

Reinhard

Seger

1 reference

17 August 2022

4

Bernd H Belohradsky

Bernd H

Belohradsky

1 reference

17 August 2022

10

Richard Mouy

Richard

Mouy

1 reference

17 August 2022

Elsbeth van Koppen

2

Elsbeth

van Koppen

1 reference

17 August 2022

Anders Ahlin

3

Anders

Ahlin

1 reference

17 August 2022

Lucien Corbeel

6

Lucien

Corbeel

1 reference

17 August 2022

Teresa Español

7

Teresa

Español

1 reference

17 August 2022

Magdalena Kurenko-Deptuch

9

Magdalena

Kurenko-Deptuch

1 reference

17 August 2022

Theoni Petropoulou

11

Theoni

Petropoulou

1 reference

17 August 2022

Niels H Valerius

15

Niels H

Valerius

1 reference

17 August 2022

Ron S Weening

16

Ron S

Weening

1 reference

17 August 2022

Baruch Wolach

17

Baruch

Wolach

1 reference

17 August 2022

Dirk Roos

18

Dirk

Roos

1 reference

Creative Commons Attribution 4.0 International

17 August 2022

language of work or name

English

0 references

publication date

2009

0 references

published in

PLOS One

0 references

volume

4

0 references

issue

4

0 references

page(s)

e5234

0 references

copyright license

start time

21 April 2009

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Special article: chronic granulomatous disease in the United Kingdom and Ireland: a comprehensive national patient-based registry

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2668749

Susceptibility to mycobacterial infections in children with X-linked chronic granulomatous disease: a review of 17 patients living in a region endemic for tuberculosis.

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2668749

Modern management of chronic granulomatous disease

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2668749

Chronic granulomatous disease in pediatric patients: 25 years of experience.

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2668749

Advances in the treatment of Chronic Granulomatous Disease by gene therapy.

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2668749

Chronic granulomatous disease (CGD) and complete myeloperoxidase deficiency both yield strongly reduced dihydrorhodamine 123 test signals but can be easily discerned in routine testing for CGD.

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2668749

Cutaneous and other lupus-like symptoms in carriers of X-linked chronic granulomatous disease: incidence and autoimmune serology

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2668749

Chronic granulomatous disease.

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2668749

Treatment of chronic granulomatous disease with myeloablative conditioning and an unmodified hemopoietic allograft: a survey of the European experience, 1985-2000.

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2668749

Genetic, biochemical, and clinical features of chronic granulomatous disease.

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2668749

Chronic granulomatous disease. Report on a national registry of 368 patients

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2668749

Chronic granulomatous disease presenting in childhood with Pseudomonas cepacia septicaemia

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2668749

Systemic lupus erythematosus in a boy with chronic granulomatous disease: case report and review of the literature

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2668749

Mutations in the X-linked and autosomal recessive forms of chronic granulomatous disease.

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2668749

Flow cytometric analysis of the granulocyte respiratory burst: a comparison study of fluorescent probes.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2668749

Clinical features, long-term follow-up and outcome of a large cohort of patients with Chronic Granulomatous Disease: an Italian multicenter study

27 September 2017

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0005234

Defective tryptophan catabolism underlies inflammation in mouse chronic granulomatous disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0005234

Gene expression profiling provides insight into the pathophysiology of chronic granulomatous disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0005234

Gastrointestinal involvement in chronic granulomatous disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0005234

Sarcoidosis in chronic granulomatous disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0005234

The molecular basis of chronic granulomatous disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0005234

Unusual late presentation of X-linked chronic granulomatous disease in an adult female with a somatic mosaic for a novel mutation in CYBB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0005234

Invasive pulmonary infection due to Scedosporium apiospermum in two children with chronic granulomatous disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0005234

Successful treatment of Paecilomyces variotii splenic abscesses: a rare complication in a previously unrecognized chronic granulomatous disease child

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0005234

BCG-osis and tuberculosis in a child with chronic granulomatous disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0005234

Long-term follow-up and outcome of 39 patients with chronic granulomatous disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0005234

Evaluation of flow cytometric methods for diagnosis of chronic granulomatous disease variants under routine laboratory conditions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0005234

Posaconazole as salvage therapy in patients with chronic granulomatous disease and invasive filamentous fungal infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0005234

Recombinant human interferon-gamma in patients with chronic granulomatous disease —European follow up study

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2668749

Successful treatment of invasive aspergillosis in chronic granulomatous disease by granulocyte transfusions followed by peripheral blood stem cell transplantation

29 November 2018

1 reference

12 December 2020

Urinary tract disorders in patients with chronic granulomatous disease

1 reference

12 December 2020

Polyarthritis resembling juvenile rheumatoid arthritis in a girl with chronic granulomatous disease

1 reference

12 December 2020

Successful treatment with voriconazole of invasive aspergillosis in chronic granulomatous disease

1 reference

12 December 2020

A simple flow cytometry assay using dihydrorhodamine for the measurement of the neutrophil respiratory burst in whole blood: comparison with the quantitative nitrobluetetrazolium test

1 reference

12 December 2020

Chorioretinal lesions in patients and carriers of chronic granulomatous disease

1 reference

12 December 2020

Recombination events between the p47-phox gene and its highly homologous pseudogenes are the main cause of autosomal recessive chronic granulomatous disease

1 reference

12 December 2020

Gene therapy for chronic granulomatous disease

1 reference

12 December 2020

10.1371/JOURNAL.PONE.0005234

Identifiers

DOI

1 reference

ADS bibcode

2009PLoSO...4.5234V

0 references

1 reference

1 reference

1 reference